Nick R. Lemoine
London, ENG EC1M6BQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
Journal: International journal of molecular sciences
Published: November 05, 2023
Correction: A Virus-infected, Reprogrammed Somatic Cell-derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2021
Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime.
Journal: Frontiers in immunology
Published: March 23, 2020
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2019
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11.
Journal: Oncotarget
Published: October 28, 2015
Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.
Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2015
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.
Journal: Molecular therapy. Methods & clinical development
Published: June 25, 2015
Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.
Journal: Journal of virology
Published: February 06, 2015
Update on oncolytic viral therapy - targeting angiogenesis.
Journal: OncoTargets and therapy
Published: August 14, 2013
Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models.
Journal: Human gene therapy
Published: July 14, 2012
Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region.
Journal: PloS one
Published: March 24, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026